Latest China News

Mount Ridley Mines reports a maiden inferred gallium resource of 838.7 million tonnes at its Mt Ridley Project, marking a significant step in Australia's critical minerals landscape amid global supply chain shifts.

Bathurst Resources reported a Q1 FY26 EBITDA of NZD 5.2 million, maintaining full-year guidance and progressing major development projects in New Zealand and Canada.

Optiscan Imaging Ltd secured $17.75 million in a fully underwritten equity raise, fueling clinical studies and regulatory preparations for its innovative medical imaging devices. The company also reported progress in international trials and strengthened its cash position to nearly $20 million.

Syrah Resources resumed graphite production at its Balama mine and advanced its Vidalia anode material facility amid supportive US trade tariffs and tax credits, positioning itself strongly in the growing EV battery market.

Zeotech Limited has locked in a $204 million binding offtake agreement for its kaolin products and successfully demonstrated its AusPozz™ low-carbon metakaolin in a large-scale concrete pour, signaling strong momentum in its commercialisation efforts.

Syrah Resources reported resumed production at its Balama graphite mine and ongoing qualification delays at its Vidalia anode material facility, while US tariffs on Chinese graphite reshape global supply chains.

Gale Pacific reports stabilising trading conditions in Q1 FY26 with a strategic U.S. operating model overhaul delivering significant cost savings, despite a slight dip in overall sales.

Greenwing Resources has launched a Stage 2 Scoping Study to explore restarting and expanding its Graphmada Graphite Mine in Madagascar, aiming to meet rising global demand and strategic supply challenges.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

CSL Limited has revised its financial outlook for FY26, citing lower US influenza vaccination rates and government cost controls in China, while postponing the planned demerger of its Seqirus vaccine business and announcing a major cost-saving program.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Lark Distilling Co. reported a 10% increase in net sales for Q1 FY26, driven by strong domestic and Asian export growth, while preparing for a major brand restage and leadership change.